DJI46,953.29+0.85%
GDAXI23,564.01+0.50%
GSPC6,700.15+1.02%
HSI25,834.02+1.45%
IXIC22,376.12+1.22%
N22553,751.15-0.13%
AAPL252.49+0.95%
AMZN212.12+2.14%
CL94.65-4.11%
EURUSD1.1523+0.88%
GBPUSD1.3335+0.85%
GC5,015.90-0.90%
GOOG304.47+1.00%
JPM286.11+0.94%
META627.72+2.37%
MSFT399.31+0.95%
NVDA183.21+1.64%
TSLA396.47+1.35%
DJI46,953.29+0.85%
GDAXI23,564.01+0.50%
GSPC6,700.15+1.02%
HSI25,834.02+1.45%
IXIC22,376.12+1.22%
N22553,751.15-0.13%
AAPL252.49+0.95%
AMZN212.12+2.14%
CL94.65-4.11%
EURUSD1.1523+0.88%
GBPUSD1.3335+0.85%
GC5,015.90-0.90%
GOOG304.47+1.00%
JPM286.11+0.94%
META627.72+2.37%
MSFT399.31+0.95%
NVDA183.21+1.64%
TSLA396.47+1.35%
DJI46,953.29+0.85%
GDAXI23,564.01+0.50%
GSPC6,700.15+1.02%
HSI25,834.02+1.45%
IXIC22,376.12+1.22%
N22553,751.15-0.13%
AAPL252.49+0.95%
AMZN212.12+2.14%
CL94.65-4.11%
EURUSD1.1523+0.88%
GBPUSD1.3335+0.85%
GC5,015.90-0.90%
GOOG304.47+1.00%
JPM286.11+0.94%
META627.72+2.37%
MSFT399.31+0.95%
NVDA183.21+1.64%
TSLA396.47+1.35%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
SWE Dagens Industri SV

Högre omsättning men större förlust för Scibase

Medicinteknikbolaget Scibase redovisar ett rörelseresultat på -26,7 miljoner kronor (-23,6) för det fjärde kvartalet 2025.

Mar 13, 2026 &03351313202631; 07:35 UTC www.di.se Trending 2/5
Read original on www.di.se ↗
↘
Negative for markets
Sentiment score: -65/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Scibase, a medical technology company, reported higher revenue but increased losses in Q4 2025, with operating loss of -26.7 million SEK compared to -23.6 million SEK in the prior year period. The deteriorating profitability despite revenue growth suggests operational challenges and cost pressures in the company's business model.
AI CONFIDENCE
75% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
↓
SCIB.ST
SCIB.STStock
Expected to decline
Widening operating losses despite revenue growth indicates deteriorating operational efficiency and profitability concerns
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
Consider reducing exposure to SCIB.ST or avoiding new positions until management provides clarity on path to profitability. Monitor upcoming earnings calls for cost reduction initiatives and margin improvement plans.
KEY SIGNALS
Operating loss increased 13% year-over-yearRevenue growth not translating to profitability improvementCost structure concerns despite higher salesNegative operating margin trend
SECTORS INVOLVED
HealthcareMedical TechnologyMedtech
Analysis generated on Mar 16, 2026 at 15:22 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Dagens Industri. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

Middle East oil exports drop at least 60% as Strait of Hormuz stays mostly closed, data shows
BNN Bloomberg Mar 16, 21:13 Negative
Bell plans $1.7B AI data centre in Saskatchewan as demand for computing power surges
BNN Bloomberg Mar 16, 21:03 Positive
Urbana Corporation Intersects 4.2 g/t Au over 10 Metres and Begins Second Drill Program
BNN Bloomberg Mar 16, 20:59 Positive
Surging gas prices threaten to reverse Canada’s inflation progress, economists say
BNN Bloomberg Mar 16, 20:46 Negative
Market Outlook: Iran conflict and oil surge raise stakes before U.S. Fed
BNN Bloomberg Mar 16, 20:43 Negative